Corporate Tech Investors

HLB Co.

HLB Co. is a corporate venture capital group that partners with technologies that align with its strategic interests.

Venture Investor Overview

Contact Information

Background Information

Overview

HBL is growing as a global anti-cancer company based on various anti-cancer drugs obtained through the global network by introducing the Open Innovation system . Under the medium-term vision of Great Goal, Beginning, we developed the next-generation immunotherapy vaccine platform, UNITE, for the best-in-class targeted anticancer drug Rivoceranib and cancer, allergies, etc. We will realize the dream of better life and extension of humanity.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/1/2020

Transaction History

Our records indicate that HLB Co. invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Yang-gon Jin

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

HLB Co. has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Hitachi Metals America | HLTH

Share this article

About Our Database of Corporate Tech Investors

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary